References
- Direcção Geral de Saúde. Programa Nacional de luta contra a tuberculose, ponto da situação epidemiológica e de desempenho, ano de 2010. Portugal: Direcção Geral de Saúde, Divisão de Doenças Transmissíveis; 2010. Available at: http://www.min-saude.pt/NR/rdonlyres/8B5396AB-E7B3-4B81-A368-F2B5F7E28F95/0/RelatorioTuberculoseDGS.pdf (Accessed November 2010).
- Chiappini E, Conti C, Galli L, Martino M. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther 2010;32:66–88.
- Alcalá L, Ruiz-Serrano MJ, Pérez-Fernández Turégano C, García de Viedma D, Díaz-Infantes M, Marín-Arriaza M, . In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother 2003;47:416–7.
- Fortún J, Martín-Dávila P, Navas E, Pérez-Elías MJ, Cobo J, Tato M, . Linezolid for the treatment of multidrug-resistant tuberculosis. J Antimicrob Chemother 2005;56: 180–5.
- Von der Lippe B, Sandven P, Brubakk O. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)—a report of ten cases. J Infect 2006;52:92–6.
- Condos R, Hadgiangelis N, Leibert E, Jacquette G, Harkin T, Rom WN. Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis. Chest 2008;134:187–92.
- Feja K, McNelley E, Tran CS, Burzynski J, Saiman L. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City From 1995 to 2003. Pediatr Infect Dis J 2008;27:907–12.
- Schaaf HS, Willemse M, Donald PR. Long-term linezolid treatment in a young child with extensively drug resistant tuberculosis. Pediatr Infect Dis J 2009;28:748–50.
- Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, . Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. J Antimicrob Chemother 2006;58:701–4.
- Myrianthefs P, Markantonis SL, Vlachos K. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother 2006; 50:3971–6.